DaVita’s international growth is promising, but shares trade at a discount. Merck faces a patent expiration, but potential solutions exist. Universal Health Services is undervalued despite growth prospects. Healthcare stocks are appealing in uncertain markets. Undervalued gems may be found in healthcare sector. Contrarian investors may benefit.

Read more at Yahoo Finance: 3 Healthcare Stocks That Are Screaming Deals Right Now